Premarket Decliner
TRDA Entrada Therapeutics16.03+0.28+1.8%
Premarket:11.00-5.03 (-31.4%)
Entrada Therapeutics Reports First Quarter 2026 Financial Results
Globe NewswireThu, 7-May 7:10 AM
